Search: WFRF:(Olsson Anna S. B.)
> (2020-2024) >
Impact of type of r...
-
Ahmed, SairahUniv Texas MD Anderson Canc Ctr, Houston, TX 77030 USA.
(author)
Impact of type of reduced-intensity conditioning regimen on the outcomes of allogeneic haematopoietic cell transplantation in classical Hodgkin lymphoma
- Article/chapterEnglish2020
Publisher, publication year, extent ...
-
2020-04-21
-
WILEY,2020
-
printrdacarrier
Numbers
-
LIBRIS-ID:oai:DiVA.org:uu-422474
-
https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-422474URI
-
https://doi.org/10.1111/bjh.16664DOI
-
http://kipublications.ki.se/Default.aspx?queryparsed=id:143442382URI
Supplementary language notes
-
Language:English
-
Summary in:English
Part of subdatabase
Classification
-
Subject category:ref swepub-contenttype
-
Subject category:art swepub-publicationtype
Notes
-
Reduced-intensity conditioning (RIC) allogeneic haematopoietic cell transplantation (allo-HCT) is a curative option for select relapsed/refractory Hodgkin lymphoma (HL) patients; however, there are sparse data to support superiority of any particular conditioning regimen. We analyzed 492 adult patients undergoing human leucocyte antigen (HLA)-matched sibling or unrelated donor allo-HCT for HL between 2008 and 2016, utilizing RIC with either fludarabine/busulfan (Flu/Bu), fludarabine/melphalan (Flu/Mel140) or fludarabine/cyclophosphamide (Flu/Cy). Multivariable regression analysis was performed using a significance level of <0 center dot 01. There were no significant differences between regimens in risk for non-relapse mortality (NRM) (P = 0 center dot 54), relapse/progression (P = 0 center dot 02) or progression-free survival (PFS) (P = 0 center dot 14). Flu/Cy conditioning was associated with decreased risk of mortality in the first 11 months after allo-HCT (HR = 0 center dot 28; 95% CI = 0 center dot 10-0 center dot 73; P = 0 center dot 009), but beyond 11 months post allo-HCT it was associated with a significantly higher risk of mortality, (HR = 2 center dot 46; 95% CI = 0 center dot 1.32-4 center dot 61; P = 0 center dot 005). Four-year adjusted overall survival (OS) was similar across regimens at 62% for Flu/Bu, 59% for Flu/Mel140 and 55% for Flu/Cy (P = 0 center dot 64), respectively. These data confirm the choice of RIC for allo-HCT in HL does not influence risk of relapse, NRM or PFS. Although no OS benefit was seen between Flu/Bu and Flu/Mel 140; Flu/Cy was associated with a significantly higher risk of mortality beyond 11 months from allo-HCT (possibly due to late NRM events).
Subject headings and genre
Added entries (persons, corporate bodies, meetings, titles ...)
-
Ghosh, NilanjanAtrium Hlth, Levine Canc Inst, Hematol Oncol & Blood Disorders, Charlotte, NC USA.
(author)
-
Ahn, Kwang W.Med Coll Wisconsin, Dept Med, CIBMTR, Milwaukee, WI 53226 USA.;Med Coll Wisconsin, Inst Hlth & Equ, Div Biostat, Milwaukee, WI 53226 USA.
(author)
-
Khanal, ManojMed Coll Wisconsin, Dept Med, CIBMTR, Milwaukee, WI 53226 USA.
(author)
-
Litovich, CarlosMed Coll Wisconsin, Dept Med, CIBMTR, Milwaukee, WI 53226 USA.
(author)
-
Mussetti, AlbertoInst Catal Oncol Hosp, Hematol Dept, Barcelona, Spain.;Hosp Llobregat, IDIBELL Inst Catala Oncol, El Prat De Llobregat, Spain.
(author)
-
Chhabra, SaurabhMed Coll Wisconsin, Dept Med, CIBMTR, Milwaukee, WI 53226 USA.;Med Coll Wisconsin, Dept Med, Div Hematol & Oncol, Milwaukee, WI 53226 USA.
(author)
-
Cairo, MitchellNew York Med Coll, Dept Pediat, Div Pediat Hematol Oncol & Stem Cell Transplantat, Valhalla, NY 10595 USA.
(author)
-
Mei, MatthewCity Hope Natl Med Ctr, Duarte, CA USA.
(author)
-
William, BasemOhio State Univ, Div Hematol, Columbus, OH 43210 USA.
(author)
-
Nathan, SunitaRush Univ, Med Ctr, Chicago, IL 60612 USA.
(author)
-
Bejanyan, NelliH Lee Moffitt Canc Ctr & Res Inst, Dept Blood & Marrow Transplant & Cellular Immunot, Tampa, FL USA.
(author)
-
Olsson, RichardUppsala universitet,Centrum för klinisk forskning i Sörmland (CKFD),Karolinska Inst, Dept Lab Med, Stockholm, Sweden.(Swepub:uu)riols677
(author)
-
Dahi, Parastoo B.Mem Sloan Kettering Canc Ctr, Dept Med, Adult Bone Marrow Transplant Serv, 1275 York Ave, New York, NY 10021 USA.
(author)
-
van der Poel, MarjoleinMaastricht Univ, Med Ctr, Maastricht, Netherlands.
(author)
-
Steinberg, AmirMt Sinai Hosp, Div Hematol & Oncol, New York, NY 10029 USA.
(author)
-
Kanakry, JenniferNCI, NIH, Bethesda, MD 20892 USA.
(author)
-
Cerny, JanUniv Massachusetts, Med Ctr, Dept Med, Div Hematol Oncol, Worcester, MA USA.
(author)
-
Farooq, UmarUniv Iowa Hosp & Clin, Div Hematol, Oncol & Blood & Marrow Transplantat, Iowa City, IA 52242 USA.
(author)
-
Seo, SachikoDokkyo Med Univ, Dept Hematol & Oncol, Mibu, Tochigi, Japan.
(author)
-
Kharfan-Dabaja, Mohamed A.Mayo Clin, Div Hematol Oncol, Blood & Marrow Transplantat Program, Jacksonville, FL 32224 USA.
(author)
-
Sureda, AnnaUniv Barcelona, Inst Catal Oncol Hosp, Hematol Dept, IDIBELL, Barcelona, Spain.
(author)
-
Fenske, Timothy S.Med Coll Wisconsin, Dept Med, Div Hematol & Oncol, Milwaukee, WI 53226 USA.
(author)
-
Hamadani, MehdiMed Coll Wisconsin, Dept Med, CIBMTR, Milwaukee, WI 53226 USA.;Med Coll Wisconsin, Dept Med, Div Hematol & Oncol, Milwaukee, WI 53226 USA.
(author)
-
Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA.Atrium Hlth, Levine Canc Inst, Hematol Oncol & Blood Disorders, Charlotte, NC USA.
(creator_code:org_t)
Related titles
-
In:British Journal of Haematology: WILEY190:4, s. 573-5820007-10481365-2141
Internet link
Find in a library
To the university's database
- By the author/editor
-
Ahmed, Sairah
-
Ghosh, Nilanjan
-
Ahn, Kwang W.
-
Khanal, Manoj
-
Litovich, Carlos
-
Mussetti, Albert ...
-
show more...
-
Chhabra, Saurabh
-
Cairo, Mitchell
-
Mei, Matthew
-
William, Basem
-
Nathan, Sunita
-
Bejanyan, Nelli
-
Olsson, Richard
-
Dahi, Parastoo B ...
-
van der Poel, Ma ...
-
Steinberg, Amir
-
Kanakry, Jennife ...
-
Cerny, Jan
-
Farooq, Umar
-
Seo, Sachiko
-
Kharfan-Dabaja, ...
-
Sureda, Anna
-
Fenske, Timothy ...
-
Hamadani, Mehdi
-
show less...
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
-
MEDICAL AND HEAL ...
-
and Clinical Medicin ...
-
and Hematology
- Articles in the publication
-
British Journal ...
- By the university
-
Uppsala University
-
Karolinska Institutet